Monoclonal Antibodies in Hospitalised Patients with COVID-19: The Role of SARS-COV-2 Serostatus in an Evolving Pandemic

Appropriately selected neutralising monoclonal antibodies (nmAbs) are an effective treatment for patients with mild or moderate coronavirus disease 2019 (COVID-19) who are at high risk of progression to severe disease. In contrast, the efficacy of nmAbs in patients hospitalised with COVID-19 has bee...

Descripción completa

Detalles Bibliográficos
Autores principales: Raffi, François, Gottlieb, Robert L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9936461/
https://www.ncbi.nlm.nih.gov/pubmed/36800149
http://dx.doi.org/10.1007/s40121-023-00769-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9936461/
https://www.ncbi.nlm.nih.gov/pubmed/36800149
http://dx.doi.org/10.1007/s40121-023-00769-2

Ejemplares similares